# City of Hope

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/city-of-hope/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74.9 |
| Citations | 3,101,700 |
| City | Lancaster |
| Country | US |
| Description | City of Hope is a research organisation in Lancaster, US. OpenAlex records 22,713 works and 3,101,700 citations for it. 5,037 researchers list it as their most recent affiliation. |
| Homepage | https://www.cityofhope.org/location/antelope-valley |
| OpenAlex ID | https://openalex.org/I4210110459 |
| Region | California |
| Researchers | 5,037 |
| ROR ID | https://ror.org/01z1vct10 |
| Type | healthcare |
| Works | 22,713 |

## University papers

Showing 12 of 57.

- [Association of reactive oxygen species levels and radioresistance in cancer stem cells](https://scholariq.org/papers/association-of-reactive-oxygen-species-levels-and-radioresistance-in-cancer-stem/)
- [Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/integration-of-palliative-care-into-standard-oncology-care-american-society-of/)
- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology](https://scholariq.org/papers/practical-assessment-and-management-of-vulnerabilities-in-older-patients/)
- [Aberrant CpG-island methylation has non-random and tumour-type–specific patterns](https://scholariq.org/papers/aberrant-cpg-island-methylation-has-non-random-and-tumour-type-specific-patterns/)
- [American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care](https://scholariq.org/papers/american-society-of-clinical-oncology-provisional-clinical-opinion-the/)
- [Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma](https://scholariq.org/papers/clinical-activity-and-molecular-correlates-of-response-to-atezolizumab-alone-or/)
- [Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells](https://scholariq.org/papers/downregulation-of-mirna-200c-links-breast-cancer-stem-cells-with-normal-stem/)
- [An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance](https://scholariq.org/papers/an-epithelial-mesenchymal-transition-gene-signature-predicts-resistance-to-egfr/)
- [Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis](https://scholariq.org/papers/breast-cancer-secreted-mir-122-reprograms-glucose-metabolism-in-premetastatic/)
- [2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines](https://scholariq.org/papers/2000-update-of-recommendations-for-the-use-of-hematopoietic-colony-stimulating/)
- [Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)](https://scholariq.org/papers/impact-of-the-addition-of-carboplatin-and-or-bevacizumab-to-neoadjuvant-once-per/)

## University researchers

- [Leonidas Arvanitis](https://scholariq.org/researchers/leonidas-arvanitis/)

## University top topics

Showing 8 of 25.

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.